Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888
41 - 50 out of 63Page size: 10
Sort by: Title

  1. On antibiotics, capital gains, China, America’s civil war, unicorns, ties - Letters to the editor

    Jonathan Darrow & Timo Minssen

    25/05/2019

    1 Media contribution

    Press/Media: Press / Media

  2. Patentstrid fortsætter for Novo

    Timo Minssen

    05/08/2016

    1 Media contribution

    Press/Media: Press / Media

  3. Pharma companies need data strategies more than ever following recent CJEU decisions

    Timo Minssen

    04/02/2020

    1 Media contribution

    Press/Media: Press / Media

  4. Podcast-interview: Unlocking the full potential of Open Innovation in the Life Sciences through a classification system, see: https://www.ebe-biopharma.eu/wp-content/uploads/2018/01/EBE_Open-Innovation-Podcast-3.mp3

    Timo Minssen & Niclas Nilsson

    14/12/2017

    1 Media contribution

    Press/Media: Press / Media

  5. Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network

    Timo Minssen

    11/12/2020

    1 Media contribution

    Press/Media: Press / Media

  6. Professor i sundhedsret: Er vi trygge ved at vaccineproduktion er ude af vores hænder?

    Timo Minssen

    19/03/2020

    1 Media contribution

    Press/Media: Press / Media

  7. Professor: En coronavaccine skal udvikles hurtigt, men vi kan ikke slække for meget på sikkerheden

    Timo Minssen

    23/03/2020

    1 Media contribution

    Press/Media: Press / Media

  8. Regulating digital health - 2020

    Timo Minssen

    01/04/2020

    1 Media contribution

    Press/Media: Press / Media

  9. Russian patents grab deemed ‘act of war’

    Timo Minssen

    16/06/2022

    1 Media contribution

    Press/Media: Press / Media

  10. SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges

    Timo Minssen

    12/05/2020

    1 Media contribution

    Press/Media: Press / Media

Previous 1 2 3 4 5 6 7 Next

ID: 16150437